Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Safety and Efficacy of Fluvastatin in Heart Transplant Recipients.

Next Previous
Trial Profile

Safety and Efficacy of Fluvastatin in Heart Transplant Recipients.

Status: Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 08 Dec 2011

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Fluvastatin (Primary)
  • Indications Cardiovascular disorders; Hypercholesterolaemia; Hyperlipidaemia
  • Focus Therapeutic Use

Most Recent Events

  • 10 May 2010 Results presented at the 30th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation.
  • 05 May 2009 Planned end date (Nov 2008) added as reported by ClinicalTrials.gov.
  • 05 May 2009 Actual patient number (56) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top